Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration

Ophthalmology

Volumn 118, Issue 12, 2011, Pages 2447-2452

  Cunningham Jr , Emmett T ^a   Feiner, Leonard ^b   Chung, Carol ^c   Tuomi, Lisa ^c   Ehrlich, Jason S ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Retina Associates of New Jersey   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VERTEPORFIN;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; MAJOR CLINICAL STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RETINA TEAR; RETROSPECTIVE STUDY; SHAM PROCEDURE; TREATMENT DURATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; DOUBLE-BLIND METHOD; FLUORESCEIN ANGIOGRAPHY; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; POSTOPERATIVE COMPLICATIONS; RETINAL PERFORATIONS; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; UNITED STATES; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 82755182750     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.05.026     Document Type: Article

References (35)

1. L.K. Chang, and D. Sarraf Tears of the retinal pigment epithelium: an old problem in a new era Retina 27 2007 523 534 (Pubitemid 46905141)
2. A.G. Casswell, D. Kohen, and A.C. Bird Retinal pigment epithelial detachments in the elderly: classification and outcome Br J Ophthalmol 69 1985 397 403 (Pubitemid 15059051)
3. L.K. Chang, C.J. Flaxel, A.K. Lauer, and D. Sarraf RPE tears after pegaptanib treatment in age-related macular degeneration Retina 27 2007 857 863 (Pubitemid 47479380)
4. A. Chiang, L.K. Chang, F. Yu, and D. Sarraf Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis Retina 28 2008 1265 1269
5. W.L. Decker, G.E. Sanborn, and M. Ridley Retinal pigment epithelial tears Ophthalmology 90 1983 507 512 (Pubitemid 13059779)
6. F. Gelisken, W. Inhoffen, and M. Partsch Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization Am J Ophthalmol 131 2001 518 520 (Pubitemid 32273446)
7. A. Hoskin, A.C. Bird, and K. Sehmi Tears of detached retinal pigment epithelium Br J Ophthalmol 65 1981 417 422 (Pubitemid 11046373)
8. D. Salz, J. Prenner, and E. Cunningham Jr. Local complications of IV anti-VEGF therapy [report online] Rev Ophthalmol 18 2010 66 75 http://www.revophth.com/content/d/retinal-insider/i/1353/c/25854/ Accessed April 14, 2011
9. M.S. Dhalla, K.J. Blinder, and A. Tewari Retinal pigment epithelial tear following intravitreal pegaptanib sodium Am J Ophthalmol 141 2006 752 754
10. A. Lommatzsch, B. Heimes, and M. Gutfleisch Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments Eye (Lond) 23 2009 2163 2168
11. R.P. Singh, and J.E. Sears Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration Am J Ophthalmol 142 2006 160 162 (Pubitemid 43946807)
12. L. Arias, J.M. Caminal, and M. Rubio Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization Eur J Ophthalmol 17 2007 992 995 (Pubitemid 351262915)
13. C.K. Chan, C.H. Meyer, and J.G. Gross Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration Retina 27 2007 541 551 (Pubitemid 46905143)
14. S. Garg, R. Brod, and D. Kim Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration Clin Experiment Ophthalmol 36 2008 252 256 (Pubitemid 351560274)
15. F. Gelisken, F. Ziemssen, and M. Voelker Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration Eye (Lond) 23 2009 694 702
16. J.P. Mathews, A. Jalil, M.J. Lavin, and P.E. Stanga Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin): optical coherence tomography and fluorescein angiographic findings [letter] Eye (Lond) 21 2007 1004 1005 (Pubitemid 47062092)
17. C.H. Meyer, S. Mennel, J.C. Schmidt, and P. Kroll Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration [letter] Br J Ophthalmol 90 2006 1207 1208 (Pubitemid 44351161)
18. M. Nicolo, D. Ghiglione, and G. Calabria Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin) Eur J Ophthalmol 16 2006 770 773 (Pubitemid 44870767)
19. S.M. Ronan, P. Yoganathan, and F.Y. Chien Retinal pigment epithelium tears after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration Retina 27 2007 535 540 (Pubitemid 46905142)
20. S. Shaikh, J.C. Olson, and P.P. Richmond Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration Indian J Ophthalmol 55 2007 470 472
21. S.J. Bakri, and A.S. Kitzmann Retinal pigment epithelial tear after intravitreal ranibizumab Am J Ophthalmol 143 2007 505 507 (Pubitemid 46273349)
22. P.E. Carvounis, A.C. Kopel, and M.S. Benz Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration Am J Ophthalmol 143 2007 504 505
23. C.K. Chan, and S.G. Lin Retinal pigment epithelial tear after ranibizumab therapy for subfoveal fibrovascular pigment epithelial detachment Eur J Ophthalmol 17 2007 674 676 (Pubitemid 351175350)
24. C. Kiss, S. Michels, and F. Prager Retinal pigment epithelium tears following intravitreal ranibizumab therapy Acta Ophthalmol Scand 85 2007 902 903 (Pubitemid 350142817)
25. L. Konstantinidis, A. Ambresin, L. Zografos, and I. Mantel Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration Acta Ophthalmol 88 2010 736 741
26. G.K. Lee, T.Y. Lai, W.M. Chan, and D.S. Lam Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration Graefes Arch Clin Exp Ophthalmol 245 2007 1225 1227 (Pubitemid 47034347)
27. B.T. Smith, C.L. Kraus, and R.S. Apte Retinal pigment epithelial tears in ranibizumab-treated eyes Retina 29 2009 335 339
28. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444 (Pubitemid 44511558)
29. C.D. Regillo, D.M. Brown, P. Abraham PIER Study Group Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1 Am J Ophthalmol 145 2008 239 248
30. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431 (Pubitemid 44511557)
31. D.M. Brown, M. Michels, P.K. Kaiser ANCHOR Study Group Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study Ophthalmology 116 2009 57 65
32. C.K. Chan, P. Abraham, and C.H. Meyer Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections Retina 30 2010 203 211
33. P. Abraham, H. Yue, and L. Wilson Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 2 Am J Ophthalmol 150 2010 315 324
34. S.P. Lesniak, H.F. Fine, J.L. Prenner, and D.B. Roth Long-term follow-up of spontaneous retinal pigment epithelium tears in age-related macular degeneration treated with anti-VEGF therapy Eur J Ophthalmol 21 2011 73 76
35. M. Leitritz, F. Gelisken, and W. Inhoffen Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study Eye (Lond) 22 2008 1504 1507